(Q34988311)

English

IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)

scientific article

Statements

IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H) (English)
0 references
0 references
Joanne L Jones
Chia-Ling Phuah
Amanda L Cox
Sara A Thompson
Jacqueline Shawcross
Amie Walton
Stephen J Sawcer
Alasdair J Coles
2052-2061

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit